Financial Advocates Investment Management’s Invesco S&P 500 Equal Weight Health Care ETF RSPH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-6,744
| Closed | -$201K | – | 718 |
|
2025
Q1 | $201K | Sell |
6,744
-1,320
| -16% | -$39.3K | 0.01% | 672 |
|
2024
Q4 | $236K | Sell |
8,064
-1,464
| -15% | -$42.9K | 0.01% | 661 |
|
2024
Q3 | $391K | Buy |
9,528
+509
| +6% | +$20.9K | 0.02% | 531 |
|
2024
Q2 | $271K | Sell |
9,019
-5,281
| -37% | -$159K | 0.02% | 596 |
|
2024
Q1 | $619K | Buy |
14,300
+7
| +0% | +$303 | 0.04% | 413 |
|
2023
Q4 | $557K | Buy |
14,293
+4,780
| +50% | +$186K | 0.04% | 407 |
|
2023
Q3 | $261K | Buy |
9,513
+13
| +0.1% | +$356 | 0.02% | 564 |
|
2023
Q2 | $283K | Sell |
9,500
-200
| -2% | -$5.96K | 0.02% | 537 |
|
2023
Q1 | $283K | Buy |
9,700
+10
| +0.1% | +$292 | 0.02% | 564 |
|
2022
Q4 | $279K | Buy |
9,690
+570
| +6% | +$16.4K | 0.02% | 573 |
|
2022
Q3 | $223K | Sell |
9,120
-3,400
| -27% | -$83.1K | 0.02% | 627 |
|
2022
Q2 | $335K | Sell |
12,520
-110
| -0.9% | -$2.94K | 0.03% | 484 |
|
2022
Q1 | $387K | Sell |
12,630
-610
| -5% | -$18.7K | 0.03% | 507 |
|
2021
Q4 | $425K | Sell |
13,240
-190
| -1% | -$6.1K | 0.03% | 524 |
|
2021
Q3 | $400K | Buy |
13,430
+10
| +0.1% | +$298 | 0.03% | 530 |
|
2021
Q2 | $393K | Buy |
13,420
+10
| +0.1% | +$293 | 0.03% | 527 |
|
2021
Q1 | $360K | Sell |
13,410
-3,810
| -22% | -$102K | 0.03% | 544 |
|
2020
Q4 | $341K | Buy |
17,220
+3,030
| +21% | +$60K | 0.02% | 534 |
|
2020
Q3 | $335K | Buy |
+14,190
| New | +$335K | 0.03% | 446 |
|
2020
Q1 | – | Sell |
-11,340
| Closed | -$251K | – | 530 |
|
2019
Q4 | $251K | Buy |
+11,340
| New | +$251K | 0.03% | 433 |
|
2019
Q3 | – | Sell |
-11,590
| Closed | -$235K | – | 497 |
|
2019
Q2 | $235K | Buy |
11,590
+860
| +8% | +$17.4K | 0.03% | 410 |
|
2019
Q1 | $212K | Buy |
+10,730
| New | +$212K | 0.03% | 426 |
|
2018
Q4 | – | Sell |
-10,950
| Closed | -$226K | – | 491 |
|
2018
Q3 | $226K | Buy |
10,950
+10
| +0.1% | +$206 | 0.03% | 453 |
|
2018
Q2 | $200K | Buy |
+10,940
| New | +$200K | 0.02% | 467 |
|